Emergent BioSolutions Inc. (EBS) Options Greeks
Options Greeks measure sensitivity to various factors: Delta (price), Gamma (delta change), Theta (time decay), and Vega (volatility). They are essential for risk management and position sizing.
Emergent BioSolutions Inc. (EBS) operates in the Healthcare sector, specifically the Drug Manufacturers - Specialty & Generic industry, with a market capitalization near $429.8M, listed on NYSE, employing roughly 900 people, carrying a beta of 2.33 to the broader market. Emergent BioSolutions Inc. Led by Joseph C. Papa Jr., public since 2006-11-15.
Snapshot as of May 15, 2026.
- Spot Price
- $7.98
- Net Gamma
- -$198.9K
- Net Delta
- -$1.2M
- Net Vega
- -$17.1K
- ATM IV
- 68.8%
- Gamma Concentration
- 0.76
As of May 15, 2026, Emergent BioSolutions Inc. (EBS) aggregate Greeks are net delta -$1.2M, net gamma -$198.9K, net vega -$17.1K, ATM IV 68.8%. Gamma concentration is 0.76: dealer gamma is tightly clustered at a few strikes, which tends to pin price. Delta measures directional exposure, gamma measures the rate of delta change, and vega measures sensitivity to implied volatility. Net aggregate Greeks summarize the total dealer book across all strikes and expirations.
How EBS options greeks Data Feeds Strategy Selection
Strategy selection on Emergent BioSolutions Inc. options does not derive from any single metric in isolation. The options greeks view above sits inside a broader read: ATM IV currently sits at 68.8% and dealer gamma exposure is negative, so dealer hedging amplifies directional moves. Combine the options greeks data here with the volatility-skew surface, dealer-gamma exposure, max-pain level, and upcoming-events calendar to build a positioning thesis. Risk-defined structures (credit spreads, debit spreads, iron condors) are usually safer than naked positions while the regime is uncertain; the data on this page anchors the inputs but does not by itself constitute a trade thesis.
Learn how options Greeks is reported and how to read the data →
Frequently asked EBS options greeks questions
- What are the EBS aggregate Greek exposures?
- As of May 15, 2026, Emergent BioSolutions Inc. (EBS) snapshot Greeks are net delta -$1.2M, net gamma -$198.9K, net vega -$17.1K. These aggregate the dealer book across all listed strikes and expirations under the standard customer-versus-dealer sign convention.
- What does the EBS net dealer delta tell us?
- Net dealer delta of -$1.2M represents the directional exposure dealers carry from their option inventory. Dealers continuously hedge this exposure with stock, futures, or correlated instruments, so the size of net delta is also the size of hedge flow that will execute as spot moves.
- How do EBS Greeks inform hedging?
- Delta tracks first-order directional exposure; gamma tracks how quickly delta changes; vega tracks IV sensitivity. Aggregated dealer Greeks let traders read the dealer-positioning regime: long-gamma regimes mean-revert moves; short-gamma regimes amplify them. Vega exposure indicates how dealer P&L responds to vol shocks and hence the direction of vol-shock hedging flows.